B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy JY231 targets tough leukemia in early trial
Disease control Recruiting nowThis early study tests the safety and initial effectiveness of an investigational cell therapy called JY231 in people with B-cell acute lymphoblastic leukemia (B-ALL). About 20 participants will receive the treatment to see if it can help control the disease. The main goal is to …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New hope for hard-to-treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study tests an experimental drug called AZD0486 in teenagers and adults with B-cell acute lymphoblastic leukemia (B-ALL) that has returned or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink or eliminate cancer cells. Part…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Experimental shot tackles tough blood cancers and anemia
Disease control Recruiting nowThis early-stage study tests a new treatment called GT801 in 28 adults with certain blood cancers (like leukemia and lymphoma) or an autoimmune blood disorder (AIHA) that have not responded to standard therapies. The goal is to see if the treatment is safe and can shrink tumors o…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for kids with tough leukemia: smarter CAR T-Cell production
Disease control Recruiting nowThis study tests a new way to make special immune cells (CAR T-cells) for children with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. The goal is to see if this new manufacturing method is safe and works better. About 89 children will take …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New hope for relapsed leukemia: experimental drug AZD4512 enters human trials
Disease control Recruiting nowThis study tests a new drug called AZD4512 in people with a hard-to-treat blood cancer called B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to other treatments. The goal is to see if the drug is safe and how well it works, either alone or with ot…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Leukemia treatment may erase vaccine immunity – study seeks answers
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) treated for B-cell acute lymphoblastic leukemia with the drug blinatumomab still have protection from routine childhood vaccines. Researchers will measure antibody levels for diseases like tetanus, hepatitis B, …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 07:39 UTC
-
CAR T-Cell survivors: what happens years later?
Knowledge-focused Recruiting nowThis study looks at the long-term health and quality of life of children and young adults who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL) at least 2 years ago. Researchers will check for late side effects, brain function, immune health, and daily l…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 07:27 UTC